Report overview
Peptide and Anticoagulant Drugs can be used to prevent endovascular embolism or thrombosis, stroke or other thrombotic diseases. It is a drug that prevents coagulation by affecting certain coagulation factors in the process of coagulation.
This report contains market size and forecasts of Peptide and Anticoagulant Drugs in global, including the following market information:
Global Peptide and Anticoagulant Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Peptide and Anticoagulant Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Peptide and Anticoagulant Drugs companies in 2021 (%)
The global Peptide and Anticoagulant Drugs market was valued at 477.3 million in 2021 and is projected to reach US$ 825.5 million by 2028, at a CAGR of 8.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormonal Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peptide and Anticoagulant Drugs include Celsus, Baxter, Hemmo Pharma, Biofer, Wockhardt, AmbioPharm, Bachem, Sun Pharmaceutical Industries and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptide and Anticoagulant Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide and Anticoagulant Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Peptide and Anticoagulant Drugs Market Segment Percentages, by Type, 2021 (%)
Hormonal
Antibiotic
ACE Inhibitor
Antifungal
Others
Global Peptide and Anticoagulant Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Peptide and Anticoagulant Drugs Market Segment Percentages, by Application, 2021 (%)
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Cardiology
Gynecology
Other Applications
Global Peptide and Anticoagulant Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Peptide and Anticoagulant Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide and Anticoagulant Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Peptide and Anticoagulant Drugs revenues share in global market, 2021 (%)
Key companies Peptide and Anticoagulant Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Peptide and Anticoagulant Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celsus
Baxter
Hemmo Pharma
Biofer
Wockhardt
AmbioPharm
Bachem
Sun Pharmaceutical Industries
Pfizer
Abbott Laboratories
Leo Pharma
Aspen
Takeda
Teva
Sanofi
Eli Lilly
Novo Nordisk
